These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3523115

  • 41. Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse.
    Caulfield MP, Higgins GA, Straughan DW.
    J Pharm Pharmacol; 1983 Feb; 35(2):131-2. PubMed ID: 6131987
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Reduction in the arginine vasopressin responses to metoclopramide and insulin-induced hypoglycemia in normal weight bulimic women.
    Chiodera P, Volpi R, Marchesi C, Caffarra P, De Ferri A, Capretti L, Speroni G, d'Amato L, Coiro V.
    Neuroendocrinology; 1993 May; 57(5):907-11. PubMed ID: 8413828
    [Abstract] [Full Text] [Related]

  • 44. Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats.
    Sherin A, Anu J, Peeyush KT, Smijin S, Anitha M, Roshni BT, Paulose CS.
    Neuroscience; 2012 Jan 27; 202():69-76. PubMed ID: 22155651
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G, Maioli M, Pacifico A, Brianda S, Palermo M, Mannelli M.
    J Clin Endocrinol Metab; 1983 Dec 27; 57(6):1145-9. PubMed ID: 6688812
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Cholinergic-mediated secretion in the rat colon: neuronal and epithelial muscarinic responses.
    Diener M, Knobloch SF, Bridges RJ, Keilmann T, Rummel W.
    Eur J Pharmacol; 1989 Sep 13; 168(2):219-29. PubMed ID: 2606150
    [Abstract] [Full Text] [Related]

  • 56. 5-HT1-, but not 5-HT2-serotonergic, M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide in man.
    Coiro V, Volpi R, Capretti L, Speroni G, Bianconi L, Cavazzini U, Marcato A, Buonanno G, Caiazza A, Chiodera P.
    Horm Res; 1990 Sep 13; 33(6):233-8. PubMed ID: 1963170
    [Abstract] [Full Text] [Related]

  • 57. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions.
    Ilcol YO, Cansev M, Yilmaz MS, Hamurtekin E, Ulus IH.
    Neurosci Lett; 2008 Jan 24; 431(1):71-6. PubMed ID: 18162319
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. No evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea.
    Roffel AF, Meurs H, Elzinga CR, Zaagsma J.
    Br J Pharmacol; 1995 Jun 24; 115(4):665-71. PubMed ID: 7582488
    [Abstract] [Full Text] [Related]

  • 60. Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity.
    Maccario M, Grottoli S, Procopio M, Oleandri SE, Boffano GM, Savio P, Camanni F, Ghigo E.
    J Endocrinol Invest; 1997 Jan 24; 20(1):8-12. PubMed ID: 9075065
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.